Drug & intervention

Tarceva

RxCUI 337526

Clinical trials10
Recruiting0
Related conditions7
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Tarceva

Wikidata Q29006532 ↗
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

10 shown
Tarceva With or Without Apatinib in the Advanced Lung AdenocarcinomaNCT02704767 · 2016-06-01
UNKNOWN
Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung CancerNCT00888511 · 2009-05-01
COMPLETED
Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast CancerNCT00739063 · 2008-07-01
TERMINATED
Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung CancerNCT00707252 · 2008-01-01
TERMINATED
Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)NCT00419042 · 2006-07-01
COMPLETED
Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLCNCT00294762 · 2006-01-01
COMPLETED
Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate CancerNCT00272038 · 2005-12-01
COMPLETED
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy RegimensNCT00294736 · 2005-11-01
COMPLETED
OSI-774 (Erlotinib, Tarceva) in Elderly PatientsNCT00200395 · 2003-07-02
COMPLETED
Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung CancerNCT00043823 · 2002-08-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.